|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Service | |||||
| Product | |||||
| Transfer of Intellectual Property and Other | |||||
| Total revenues | |||||
| Costs and expenses: | |||||
| Cost of Goods and Services Sold | |||||
| Service | |||||
| Product | |||||
| Total cost of Goods and Services Sold | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Contingent consideration | |||||
| Amortization of intangible assets | |||||
| Gain on sale of assets | |||||
| Total costs and expenses | |||||
| Operating loss | |||||
| Other income and (expense), net: | |||||
| Interest income | |||||
| Interest expense | |||||
| Fair value changes of derivative instruments, net | |||||
| Other income (expense), net | |||||
| Loss before income taxes and investment losses | |||||
| Income tax benefit (provision) | |||||
| Net loss before investment losses | |||||
| Loss from investments in investees | |||||
| Net loss | |||||
| Loss per share basic and diluted: | |||||
| Loss per share Basic | |||||
| Loss per share diluted | |||||
| Weighted average number of common shares outstanding, basic | |||||
| Weighted average number of common shares outstanding, diluted | |||||
Loading...